Cliniques universitaires Saint-Luc, Brussels, Belgium has ordered a DrugLog® system. The system will be used for the final control of cytotoxic drugs at the hospital pharmacy. The agreement is entered into with Pharmacolog France SARL and is the first installation of DrugLog® in Belgium.
Clinique universitaires Saint-Luc (UCL) is Brussels’ largest hospital with 5,800 employees and 970 beds. In addition to providing optimal patient care, Saint-Luc collaborates with the Université Catholique de Louvain in research, innovation and teaching. UCL has a comprehensive non-sterile and sterile device that includes preparations for chemotherapy. UCL Saint Luc has now signed an agreement with Pharmacolog France SARL to install DrugLog® which will be used to control the cytotoxic drugs. The order value is approximately SEK 700,000 over a period over three years.
Didier Dubois, Sales Manager Pharmacolog SARL comments: “I am pleased that UCL Saint Luc has decided to install DrugLog® to perform quality control of its prepared cytotoxic preparations. DrugLog® will be an excellent complement to the already high safety standards that are being practiced in Saint-Luc. A big thank you to the staff at UCL for their confidence in the implementation of this project. UCL Saint Luc and Pharmacolog are now collaborating to strengthen patient safety. From Pharmacolog’s perspective, it is also very gratifying to break into the Belgian market with this first installation.”
This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on April 1st, 2021 at 10:45.
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.